Results 141 to 150 of about 72,950 (205)

Plain language summary of the direct oral anticoagulant switch study: effect of switching or continuing apixaban or rivaroxaban among people with non-valvular atrial fibrillation. [PDF]

Future Cardiol
Deitelzweig S, Jiang J, Subash R, Cheng D, Lip GYH.   +4 more
europepmc   +1 more source

Optimal direct oral anticoagulant for upper gastrointestinal endoscopic submucosal dissection. [PDF]

J Gastroenterol
Ono Y, Hatta W, Tarasawa K, Ogata Y, Abe H, Sato I, Hatayama Y, Saito M, Jin X, Uno K, Koike T, Imatani A, Hamada S, Fujimori K, Fushimi K, Masamune A.   +15 more
europepmc   +1 more source

Increased direct oral anticoagulant use and event rates in non-valvular atrial fibrillation: a nationwide retrospective registry study in Sweden. [PDF]

BMJ Open
Kadhim H, Jansson M, Själander S, Sjögren V, Björck F, Renlund H, Eriksson M, Norrving B, Själander A.   +8 more
europepmc   +1 more source

Evaluation of extended direct oral anticoagulant dosing strategies in patients with and without cancer from a prospective observational registry. [PDF]

Res Pract Thromb Haemost
Vlazny DT, McBane RD, Casanegra AI, Hodge DO, Lang T, Wysokinski WE, Peterson L, Houghton DE.   +7 more
europepmc   +1 more source

Challenges and Opportunities of Direct Oral Anticoagulant (DOAC) Therapy in Complex Clinical Scenarios: A Comprehensive Review and Practical Guide. [PDF]

J Clin Med
Miceli G, Ciaccio AM, Tuttolomondo A.
europepmc   +1 more source

Association of Direct Oral Anticoagulant-Proton Pump Inhibitor Co-Therapy with Adverse Outcomes: A Population-Based Cohort Study. [PDF]

Ann Pharmacother
Wang M, Paterson JM, Nguyen F, Siegal DM, Targownik L, Holbrook AM.   +5 more
europepmc   +1 more source

Impact of levetiracetam on direct oral anticoagulant level and outcomes among older Asian patients with atrial fibrillation. [PDF]

Front Pharmacol
Huang YT, Chen TL, Huang YL, Kuo CH, Peng YF, Tang SC, Jeng JS, Huang CF, Lin SY, Lin FJ.   +9 more
europepmc   +1 more source

Assessment of Long-Term Use Versus Discontinuation of Direct Oral Anticoagulant After Catheter Ablation for Atrial Fibrillation-RYOUMA Registry Subanalysis. [PDF]

Ann Noninvasive Electrocardiol
Oda Y, Nogami A, Komatsu Y, Soejima K, Morishima I, Hiroshima K, Kato R, Sakagami S, Miura F, Okawa K, Fukuzawa M, Takita A, Uno K, Kumagai K, Kurita T, Gosho M, Ishizu T, Aonuma K, RYOUMA Investigators.   +18 more
europepmc   +1 more source

196 Implementation of a Centralized Direct Oral Anticoagulant Surveillance Program

Research and Practice in Thrombosis and Haemostasis
Sandra Hedin, Melissa Fontana, Briana Ballister   +2 more
doaj   +1 more source